Merck
  • Home
  • Search Results
  • Intranasal angiotensin II in humans reduces blood pressure when angiotensin II type 1 receptors are blocked.

Intranasal angiotensin II in humans reduces blood pressure when angiotensin II type 1 receptors are blocked.

Hypertension (Dallas, Tex. : 1979) (2014-01-15)
Inge Derad, Friedhelm Sayk, Hendrik Lehnert, Lisa Marshall, Jan Born, Martin Nitschke
ABSTRACT

Intranasal administration of angiotensin II (ANGII) affects blood pressure in a mode different from intravenously administered ANGII via a direct access to the brain bypassing the blood-brain barrier. This clinical study investigated blood pressure regulation after intranasal ANGII administration in healthy humans, whereas systemic, blood-mediated effects of ANGII were specifically blocked. In a balanced crossover design, men (n=8) and women (n=8) were intranasally administered ANGII (400 μg) or placebo after ANGII type 1 receptors had been blocked by pretreatment with valsartan (80 mg; 12 and 6 hours before intranasal administration). Plasma levels of ANGII, aldosterone, renin, vasopressin, and norepinephrine were measured; blood pressure and heart rate were recorded continuously. Intranasal ANGII acutely decreased blood pressure without altering the heart rate. Plasma levels of vasopressin and norepinephrine remained unaffected. Plasma ANGII levels were increased throughout the recording period. Aldosterone levels increased despite the peripheral ANGII type 1 receptor blockade, indicating an aldosterone escape phenomenon. In conclusion, intranasal ANGII reduces blood pressure in the presence of selective ANGII type 1 receptor blockade. Intranasal ANGII administration represents a useful approach for unraveling the role of this peptide in blood pressure regulation in humans.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
人血管紧张素 II, ≥93% (HPLC), powder
Sigma-Aldrich
L -缬氨酸, reagent grade, ≥98% (HPLC)
Sigma-Aldrich
醛固酮, ≥95% (HPLC)
Sigma-Aldrich
L -缬氨酸, from non-animal source, meets EP, JP, USP testing specifications, suitable for cell culture, 98.5-101.0%
Supelco
缬沙坦, Pharmaceutical Secondary Standard; Certified Reference Material
SAFC
L -缬氨酸
Supelco
L-缬氨酸, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
醛固酮标准液 溶液, 100 μg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®
Sigma-Aldrich
缬沙坦, ≥98% (HPLC)
Sigma-Aldrich
L -缬氨酸, BioUltra, ≥99.5% (NT)
USP
缬沙坦, United States Pharmacopeia (USP) Reference Standard
缬氨酸, European Pharmacopoeia (EP) Reference Standard
Supelco
L -缬氨酸, certified reference material, TraceCERT®
缬沙坦, European Pharmacopoeia (EP) Reference Standard
缬沙坦, European Pharmacopoeia (EP) Reference Standard
缬沙坦, European Pharmacopoeia (EP) Reference Standard